LoginRegister

    Cadila Healthcare gets OAI letter from USFDA for Moraiya facility

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  

    The company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila Healthcare said in a filing to the BSE.


    New Delhi: Drug firm Cadila Healthcare on August 7 said the US health regulator has classified inspection of the company's Moraiya facility in Gujarat as 'official action indicated' (OAI).


    According to the United States Food and Drug Administration (USFDA), OAI means regulatory and/or administrative actions will be recommended.


    Read Also: Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

    The company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila Healthcare said in a filing to the BSE.


    "The company believes that this classification will not have any impact on the current supplies or revenues of this facility," it added.


    Cadila Healthcare is in the process of sending further updates of its corrective actions to the USFDA and remains hopeful of a positive outcome, the company said.


    Read Also: Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

    +USFDA ObservationBSECadila HealthcareCadila inspectionDrug firmHealthcareMoraiya facilityoaiOfficial Action Indicatedpharmapharma companypharma newspharma news indiaUSFDAzydus
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X